Pfizer Inc (PFE) | |||
---|---|---|---|
49.86 0.11 (0.22%) | 08-16 16:04 | ||
Open: | 49.38 | Pre. Close: | 49.75 |
High: | 50.18 | Low: | 49.36 |
Volume: | 12,519,784 | Market Cap: | 279,832M |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 50.227 - 50.47 | 50.47 - 50.68 |
Low: | 48.774 - 49.057 | 49.057 - 49.301 |
Close: | 49.438 - 49.875 | 49.875 - 50.252 |
Stock Technical Analysis | |
---|---|
Overall: | ![]() |
Target: | Six months: 59.48 One year: 61.73 |
Support: | Support1: 47.81 Support2: 39.78 |
Resistance: | Resistance1: 50.92 Resistance2: 52.85 |
Pivot: | 49.98 ![]() |
Moving Averages: | MA(5): 49.59 ![]() MA(20): 50.35 ![]() MA(100): 51.02 ![]() MA(250): 50.24 ![]() |
MACD: | MACD(12,26): -0.47 ![]() Signal(12,26,9): -0.43 ![]() |
%K %D: | %K(14,3): 43.16 ![]() %D(3): 33.79 ![]() |
RSI: | RSI(14): 46.48 ![]() |
52-Week: | High: 61.71 Low: 40.94 Change(%): 3.1 |
Average Vol(K): | 3-Month: 20385 10-Days: 18343 |
Price, MAs and Bollinger Bands |
---|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PFE ] has closed above bottom band by 46.0%. Bollinger Bands are 43.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend. |
Stock chart |
---|
![]() |
Financial Analysis | |
---|---|
Price to Book Value: | Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
Price to Earnings: | Outperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
Discounted cash flow: | Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
Return on Assets: | Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
Return on Equity: | Outperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
Debt to Equity: | Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Stock Basics & Statistics | |
---|---|
Exchange: New York Stock Exchange | |
Sector: Healthcare | |
Industry: Drug Manufacturers—General | |
Shares Out. (M) | 5610.00 |
Shares Float (M) | 5610.00 |
% Held by Insiders | 0.04 |
% Held by Institutions | 69.13 |
Shares Short (K) | 67350 |
Shares Short Prior Month (K) | 76980 |
Stock Financials | |
---|---|
EPS | 5.180 |
Book Value (p.s.) | 14.740 |
Profit Margin | 28.94 |
Operating Margin | 37.61 |
Return on Assets (ttm) | |
Return on Equity (ttm) | |
Qtrly Rev. Growth | 46.2 |
Gross Profit (p.s.) | 9.025 |
Sales Per Share | 18.053 |
EBITDA (p.s.) | 7.676 |
Qtrly Earnings Growth | 76.40 |
Operating Cash Flow (M) | |
Levered Free Cash Flow (M) |
Stock Valuation | |
---|---|
PE Ratio | 9.63 |
PEG Ratio | |
Price to Book value | 3.38 |
Price to Sales | 2.76 |
Price to Cash Flow |
Stock Dividends | |
---|---|
Dividend | 0.400 |
Dividend Yield | 0.01 |
Dividend Growth |